The Effect of Titanium Dioxide Nanoparticles on Pulmonary Surfactant Function and Ultrastructure

Overview

Journal Respir Res

Specialty Pulmonary Medicine

Date 2009 Oct 2

PMID 19793393

Citations 22

Authors

Carsten Schleh

Christian Muhlfeld

Karin Pulskamp

Andreas Schmiedl

Matthias Nassimi

Hans D Lauenstein

Armin Braun

Norbert Krug

Veit J Erpenbeck

Jens M Hohlfeld

Affiliations

Soon will be listed here.

Abstract

Background: Pulmonary surfactant reduces surface tension and is present at the air-liquid interface in the alveoli where inhaled nanoparticles preferentially deposit. We investigated the effect of titanium dioxide (TiO(2)) nanosized particles (NSP) and microsized particles (MSP) on biophysical surfactant function after direct particle contact and after surface area cycling in vitro. In addition, TiO(2) effects on surfactant ultrastructure were visualized.

Methods: A natural porcine surfactant preparation was incubated with increasing concentrations (50-500 microg/ml) of TiO(2) NSP or MSP, respectively. Biophysical surfactant function was measured in a pulsating bubble surfactometer before and after surface area cycling. Furthermore, surfactant ultrastructure was evaluated with a transmission electron microscope.

Results: TiO(2) NSP, but not MSP, induced a surfactant dysfunction. For TiO(2) NSP, adsorption surface tension (gammaads) increased in a dose-dependent manner from 28.2 + or - 2.3 mN/m to 33.2 + or - 2.3 mN/m (p < 0.01), and surface tension at minimum bubble size (gammamin) slightly increased from 4.8 + or - 0.5 mN/m up to 8.4 + or - 1.3 mN/m (p < 0.01) at high TiO(2) NSP concentrations. Presence of NSP during surface area cycling caused large and significant increases in both gammaads (63.6 + or - 0.4 mN/m) and gammamin (21.1 + or - 0.4 mN/m). Interestingly, TiO(2) NSP induced aberrations in the surfactant ultrastructure. Lamellar body like structures were deformed and decreased in size. In addition, unilamellar vesicles were formed. Particle aggregates were found between single lamellae.

Conclusion: TiO(2) nanosized particles can alter the structure and function of pulmonary surfactant. Particle size and surface area respectively play a critical role for the biophysical surfactant response in the lung.

Citing Articles

Occupational exposure and health surveys at metal additive manufacturing facilities.

Assenhoj M, Almstrand A, Kokelj S, Ljunggren S, Olin A, Karlsson H Front Public Health. 2023; 11:1292420.

PMID: 38054074 PMC: 10694287. DOI: 10.3389/fpubh.2023.1292420.

Determinants and mechanisms of inorganic nanoparticle translocation across mammalian biological barriers.

Cary C, Stapleton P Arch Toxicol. 2023; 97(8):2111-2131.

PMID: 37303009 PMC: 10540313. DOI: 10.1007/s00204-023-03528-x.

Lung surfactant as a biophysical assay for inhalation toxicology.

Liu J, Sayes C Curr Res Toxicol. 2023; 4:100101.

PMID: 36687216 PMC: 9849875. DOI: 10.1016/j.crtox.2022.100101.

Revealing the pulmonary surfactant corona on silica nanoparticles by cryo-transmission electron microscopy.

Mousseau F, Oikonomou E, Vacher A, Airiau M, Mornet S, Berret J Nanoscale Adv. 2022; 2(2):642-647.

PMID: 36133230 PMC: 9416877. DOI: 10.1039/c9na00779b.

An adverse outcome pathway for lung surfactant function inhibition leading to decreased lung function.

Da Silva E, Vogel U, Hougaard K, Perez-Gil J, Zuo Y, Sorli J Curr Res Toxicol. 2021; 2:225-236.

PMID: 34345865 PMC: 8320609. DOI: 10.1016/j.crtox.2021.05.005.

References

Bakshi M, Zhao L, Smith R, Possmayer F, Petersen N . Metal nanoparticle pollutants interfere with pulmonary surfactant function in vitro. Biophys J. 2007; 94(3):855-68. PMC: 2186259. DOI: 10.1529/biophysj.107.106971. View

Inoue K, Takano H, Yanagisawa R, Ichinose T, Sakurai M, Yoshikawa T . Effects of nano particles on cytokine expression in murine lung in the absence or presence of allergen. Arch Toxicol. 2006; 80(9):614-9. DOI: 10.1007/s00204-006-0075-3. View

Effros R, Feng N, Mason G, Sietsema K, Silverman P, Hukkanen J . Solute concentrations of the pulmonary epithelial lining fluid of anesthetized rats. J Appl Physiol (1985). 1990; 68(1):275-81. DOI: 10.1152/jappl.1990.68.1.275. View

Schleh C, Hohlfeld J . Interaction of nanoparticles with the pulmonary surfactant system. Inhal Toxicol. 2009; 21 Suppl 1:97-103. DOI: 10.1080/08958370903005744. View

Jiang C, Gamarnik A, Tripp C . Identification of lipid aggregate structures on TiO2 surface using headgroup IR bands. J Phys Chem B. 2006; 109(10):4539-44. DOI: 10.1021/jp046042h. View

Holm B, Notter R, Finkelstein J . Surface property changes from interactions of albumin with natural lung surfactant and extracted lung lipids. Chem Phys Lipids. 1985; 38(3):287-98. DOI: 10.1016/0009-3084(85)90022-2. View

Griese M, Birrer P, Demirsoy A . Pulmonary surfactant in cystic fibrosis. Eur Respir J. 1997; 10(9):1983-8. DOI: 10.1183/09031936.97.10091983. View

FERIN J, Oberdorster G, Penney D . Pulmonary retention of ultrafine and fine particles in rats. Am J Respir Cell Mol Biol. 1992; 6(5):535-42. DOI: 10.1165/ajrcmb/6.5.535. View

Sayes C, Marchione A, Reed K, Warheit D . Comparative pulmonary toxicity assessments of C60 water suspensions in rats: few differences in fullerene toxicity in vivo in contrast to in vitro profiles. Nano Lett. 2007; 7(8):2399-406. DOI: 10.1021/nl0710710. View

10.

Ku T, Gill S, Lobenberg R, Azarmi S, Roa W, Prenner E . Size dependent interactions of nanoparticles with lung surfactant model systems and the significant impact on surface potential. J Nanosci Nanotechnol. 2008; 8(6):2971-8. DOI: 10.1166/jnn.2008.171. View

11.

Kendall M . Fine airborne urban particles (PM2.5) sequester lung surfactant and amino acids from human lung lavage. Am J Physiol Lung Cell Mol Physiol. 2007; 293(4):L1053-8. DOI: 10.1152/ajplung.00131.2007. View

12.

Kanno S, Furuyama A, Hirano S . Effects of eicosane, a component of nanoparticles in diesel exhaust, on surface activity of pulmonary surfactant monolayers. Arch Toxicol. 2008; 82(11):841-50. DOI: 10.1007/s00204-008-0306-x. View

13.

Fortunelli A, Monti S . Simulations of lipid adsorption on TiO2 surfaces in solution. Langmuir. 2008; 24(18):10145-54. DOI: 10.1021/la801787s. View

14.

Putz G, GOERKE J, Taeusch H, Clements J . Comparison of captive and pulsating bubble surfactometers with use of lung surfactants. J Appl Physiol (1985). 1994; 76(4):1425-31. DOI: 10.1152/jappl.1994.76.4.1425. View

15.

Kirkham P, Rahman I . Oxidative stress in asthma and COPD: antioxidants as a therapeutic strategy. Pharmacol Ther. 2006; 111(2):476-94. DOI: 10.1016/j.pharmthera.2005.10.015. View

16.

Beatty A, Malloy J, Wright J . Pseudomonas aeruginosa degrades pulmonary surfactant and increases conversion in vitro. Am J Respir Cell Mol Biol. 2004; 32(2):128-34. DOI: 10.1165/rcmb.2004-0276OC. View

17.

Hohlfeld J, Ahlf K, ENHORNING G, Balke K, Erpenbeck V, Petschallies J . Dysfunction of pulmonary surfactant in asthmatics after segmental allergen challenge. Am J Respir Crit Care Med. 1999; 159(6):1803-9. DOI: 10.1164/ajrccm.159.6.9806145. View

18.

Veldhuizen R, Yao L, Lewis J . An examination of the different variables affecting surfactant aggregate conversion in vitro. Exp Lung Res. 1999; 25(2):127-41. DOI: 10.1080/019021499270349. View

19.

Collaco J, Vanscoy L, Bremer L, Mcdougal K, Blackman S, Bowers A . Interactions between secondhand smoke and genes that affect cystic fibrosis lung disease. JAMA. 2008; 299(4):417-24. PMC: 3139475. DOI: 10.1001/jama.299.4.417. View

20.

Veldhuizen R, Yao L, Hearn S, Possmayer F, Lewis J . Surfactant-associated protein A is important for maintaining surfactant large-aggregate forms during surface-area cycling. Biochem J. 1996; 313 ( Pt 3):835-40. PMC: 1216986. DOI: 10.1042/bj3130835. View